Therapeutic strategies for localized prostate cancer.

Authors

• J H Lynch
• J T Batuello
• E D Crawford
• L G Gomella
• J Kaufman
• D P Petrylak
• A B Joel

Publication/Presentation Date

1-1-2001

Abstract

Prostate-specific antigen determinations for prostate cancer screening have led to a dramatic increase in the number of men who are diagnosed with organ-confined and therefore potentially curable prostate cancer. Advances in predicting outcomes with artificial neural networks may help to recommend one therapy over another. Less invasive forms of treatment, such as high-intensity focused ultrasound, may ultimately give patients additional options for treatment. Furthermore, attempts to better define the role of both neoadjuvant hormonal therapy and chemotherapy may give higher-risk patients better outcomes than with current treatments. These advances as well as continued research will likely lead to a day when more and more men with organ-confined disease will be cured.

Volume

3 Suppl 2

Issue

Suppl 2

First Page

39

Last Page

48

ISSN

1523-6161

Published In/Presented At

Lynch, J. H., Batuello, J. T., Crawford, E. D., Gomella, L. G., Kaufman, J., Petrylak, D. P., & Joel, A. B. (2001). Therapeutic strategies for localized prostate cancer. Reviews in urology, 3 Suppl 2(Suppl 2), S39–S48.

Disciplines

Business Administration, Management, and Operations | Health and Medical Administration | Management Sciences and Quantitative Methods

PubMedID

16985999

Department(s)

Administration and Leadership

Document Type

Article